MC10
Medidata said the deal will help better integrate clinical-grade metrics into its remote trial platform and broadly support the use of wearable sensors for clinical research.
The pair plans to use MC10's FDA-cleared wearable sensors, called BioStamp nPoint, to get insights into a patient's physiological data during the studies.